Endo Sues Noven To Protect The Market For Lidoderm
Endo Pharmaceuticals Inc. hit Noven Pharmaceuticals Inc. with a patent suit in Delaware on Friday over Noven's recent bid for U.S. regulatory approval to make and sell a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article